Credit Suisse cuts Pfizer to hold, prefers Merck, J&J
July 20, 2017 at 14:57 PM EDT
Credit Suisse downgraded Pfizer to Neutral from Outperform, saying that the company's positive catalysts will become "more limited" over the next six to twelve months.
